AQR Capital Management
MRVI icon

AQR Capital Management’s Maravai LifeSciences MRVI Stock Holding History

AQR Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Sell
82,536
-28,595
-26% -$96.9K ﹤0.01% 3530
2025
Q4 		$361K Buy
111,131
+49,551
+80% +$167K ﹤0.01% 3084
2025
Q3 		$177K Buy
61,580
+1,740
+3% +$4.44K ﹤0.01% 3283
2025
Q2 		$144K Buy
59,840
+44,313
+285% +$93.1K ﹤0.01% 3118
2025
Q1 		$34.3K Sell
15,527
-35,835
-70% -$142K ﹤0.01% 3103
2024
Q4 		$280K Sell
51,362
-268,107
-84% -$1.73M ﹤0.01% 2516
2024
Q3 		$2.65M Sell
319,469
-453,544
-59% -$3.92M ﹤0.01% 1357
2024
Q2 		$5.53M Sell
773,013
-2,052,862
-73% -$17.7M 0.01% 975
2024
Q1 		$24.2M Sell
2,825,875
-678,236
-19% -$4.59M 0.04% 461
2023
Q4 		$23M Buy
3,504,111
+1,755,108
+100% +$11.3M 0.04% 461
2023
Q3 		$17.2M Buy
1,749,003
+779,838
+80% +$8.56M 0.04% 515
2023
Q2 		$12M Sell
969,165
-322,889
-25% -$4.36M 0.03% 613
2023
Q1 		$18M Sell
1,292,054
-168,598
-12% -$2.42M 0.04% 501
2022
Q4 		$20.8M Buy
1,460,652
+602,852
+70% +$9.49M 0.05% 465
2022
Q3 		$21.9M Buy
857,800
+264,660
+45% +$6.64M 0.05% 413
2022
Q2 		$16.1M Buy
593,140
+441,489
+291% +$14M 0.04% 550
2022
Q1 		$5.35M Buy
151,651
+146,519
+2,855% +$4.91M 0.01% 836
2021
Q4 		$215K Buy
+5,132
New +$208K ﹤0.01% 2068

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management's MRVI Position: Q1 2026 in Review

AQR Capital Management reduced its Maravai LifeSciences (MRVI) stake by 26% in Q1 2026, selling an estimated $96.9K and leaving 82,536 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #3530.

AQR Capital Management first reported a position in MRVI in Q4 2021 and has held it in 18 quarters since. The position peaked at $24.2M in Q1 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • AQR Capital Management held 82,536 shares of Maravai LifeSciences worth $234K as of Q1 2026.
  • AQR Capital Management sold 28,595 Maravai LifeSciences shares in Q1 2026, an estimated $96.9K.
  • Maravai LifeSciences made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3530 holding.
  • AQR Capital Management first reported a position in Maravai LifeSciences in Q4 2021 and has held it in 18 quarters since.
  • AQR Capital Management's Maravai LifeSciences position peaked at $24.2M in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.